Recent Company News

• 10:00 AM ET Jun 26, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (246 total)

• 10:01 AM ET Jun 25, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (324 total)

• 09:15 AM ET Jun 12, 2026
  

  EMA's PRAC makes recommendations during June 2026 meeting, including Tavneos, Ixchiq, and valproate

• 12:37 PM ET Jun 03, 2026
  

  Transcript Intelligence : Valneva à la Jefferies Global Healthcare Conference

• 12:37 PM ET Jun 03, 2026
  

  Transcript Intelligence: Valneva at Jefferies Global Healthcare Conference

• 11:05 AM ET May 13, 2026
  

  Transcript Intelligence: Valneva Q1 Earnings Guidance

• 11:05 AM ET May 13, 2026
  

  Transcript Intelligence: Valneva Q1 Earnings Themes

• 11:05 AM ET May 13, 2026
  

  Transcript Intelligence: Valneva Q1 Earnings Q&A

• 01:10 AM ET May 13, 2026
  

  Valneva reports Q1 net income (€32.1M) vs FactSet (€13.3M) [3 est, (€15.9)-(8.4M)]; cuts revenue guide to €145M - €160M from €155M - 170M; plans further restructuring, including 10-15% global workforce reduction (€2.53, 0.00)

• 10:01 AM ET May 10, 2026
  

  INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN